Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated scores highest on Nitro (85) and lowest on Price (33). Its PosiPenta is 62.98 out of 100, better than most similar companies.
On the Penta Grid this week, Vertex Pharmaceuticals Incorporated is Grid #97 of 837 in the Healthcare sector in United States, and Grid #350 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | 62.98 | 33 | 66 | 85 | 71 | 61 |
| Bristol-Myers Squibb Company | 67.05 | 50 | 73 | 85 | 53 | 74 |
| CVS Health Corporation | 69.38 | 61 | 88 | 80 | 49 | 69 |
| McKesson Corporation | 72.92 | 23 | 73 | 99 | 98 | 71 |
| Stryker Corporation | 63.30 | 36 | 82 | 64 | 57 | 78 |
| Intuitive Surgical, Inc. | 58.62 | 18 | 72 | 68 | 88 | 47 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 28.94 |
| P/B ratio | 6.26 |
EEarnings
| Trailing EPS | ₹1635.73 |
| Forward EPS | ₹1914.91 |
NNitro
| Price | 47332.85 |
| 52-week high | 53064.05 |
| 52-week low | 38185.28 |
| Fall from 52-week high | 10.8% |
TTorque
| Return on equity (ROE) | 23.54% |
| Debt-to-equity | 0.10 |
AAnchor
| Beta (price swings) | 0.28 |
| Market cap | ₹11,99,702 Cr |
| Insider holding | 0.21% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Vertex Pharmaceuticals Incorporated's PosiPenta score?
Vertex Pharmaceuticals Incorporated's PosiPenta is 62.98 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Vertex Pharmaceuticals Incorporated stand on the Penta Grid?
On the Penta Grid this week, Vertex Pharmaceuticals Incorporated is Grid #97 of 837 in the Healthcare sector in United States, and Grid #350 of 4,000 in United States.
Which PosiPenta pillar is strongest for Vertex Pharmaceuticals Incorporated?
Nitro (momentum), with a score of 85 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Vertex Pharmaceuticals Incorporated?
Price (valuation), with a score of 33 out of 100: weaker than most similar companies.
Has Vertex Pharmaceuticals Incorporated's PosiPenta changed since last week?
Yes, it rose 5.39 points, from 57.59 to 62.98.
PositoAI is for research and education only and is not investment advice.